Jennison Associates LLC Buys Shares of 149,584 Align Technology, Inc. $ALGN

Jennison Associates LLC bought a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 149,584 shares of the medical equipment provider’s stock, valued at approximately $23,358,000.

A number of other hedge funds have also added to or reduced their stakes in ALGN. Wealth Enhancement Advisory Services LLC lifted its position in shares of Align Technology by 38.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 15,551 shares of the medical equipment provider’s stock worth $2,029,000 after purchasing an additional 4,359 shares during the period. AE Wealth Management LLC purchased a new stake in shares of Align Technology in the 3rd quarter worth about $650,000. Dana Investment Advisors Inc. purchased a new stake in shares of Align Technology in the 3rd quarter worth about $9,991,000. AIA Group Ltd purchased a new stake in shares of Align Technology in the 3rd quarter worth about $2,507,000. Finally, Hussman Strategic Advisors Inc. purchased a new stake in shares of Align Technology in the 3rd quarter worth about $3,156,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Up 1.6%

ALGN opened at $178.91 on Friday. The firm has a 50 day moving average price of $179.02 and a 200-day moving average price of $164.00. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $208.30. The stock has a market capitalization of $12.81 billion, a price-to-earnings ratio of 30.02, a PEG ratio of 1.91 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share for the quarter, beating the consensus estimate of $2.26 by $0.32. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the company earned $2.13 earnings per share. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, analysts expect that Align Technology, Inc. will post 9.15 earnings per share for the current year.

Align Technology declared that its board has authorized a stock repurchase plan on Wednesday, April 29th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to repurchase up to 1.6% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its shares are undervalued.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q1 earnings beat and operational momentum — ALGN reported $2.58 EPS vs. $2.26 expected and roughly $1.04B revenue (above estimates). Management highlighted record Invisalign shipments, rising margins and steady global demand. This beat is the primary near-term driver. Align Technology beats quarterly estimates, plans $200 million buyback (Reuters)
• Positive Sentiment: $200 million share repurchase program — Align’s board authorized up to $200M (≈1.6% of shares) for buybacks, signaling management confidence and supporting EPS/cash-return expectations. Align Technology announces $200M share repurchase (MassDevice)
• Positive Sentiment: Analyst price-target increases — Evercore raised its target to $220 (from $200) and Leerink raised to $230 (from $225), both reflecting a meaningful upside to the current price and validating the beat/buyback story. Evercore raises ALGN target to $220 (MarketScreener) Leerink raises ALGN target to $230 (MarketScreener)
• Positive Sentiment: Earnings call reinforced product momentum — Management commentary emphasized global aligner demand and iTero scanner/ software traction, supporting medium-term growth expectations. Earnings Call Highlights (TipRanks)
• Neutral Sentiment: Product and innovation showcase at AAO — Align previewed 2026 innovations at the AAO session, which supports long-term adoption but is incremental to today’s headline drivers. AAO preview (BusinessWire)
• Negative Sentiment: Near-term limits to upside — despite positive headlines, valuation and market technicals could temper gains: ALGN trades at a ~30x P/E and intraday volume has been below average, which may cap momentum until follow-through earnings/cash-return evidence emerges.

Insider Buying and Selling at Align Technology

In other news, EVP John Morici sold 7,969 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the completion of the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at $1,559,346.47. The trade was a 49.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.75% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on ALGN. Jefferies Financial Group raised their target price on shares of Align Technology from $155.00 to $185.00 and gave the stock a “hold” rating in a research report on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Align Technology in a research report on Wednesday, April 15th. Morgan Stanley lifted their price target on shares of Align Technology from $169.00 to $188.00 and gave the company an “equal weight” rating in a research report on Friday, April 24th. Mizuho lifted their price target on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Finally, Piper Sandler lifted their price target on shares of Align Technology from $220.00 to $235.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $205.85.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.